Results 81 to 90 of about 13,126 (223)

The Role of Pharmacovigilance Database in Identifying Antibiotic Resistance and Inappropriate Use: An Analysis of VigiBase Reports From Lower‐Middle‐Income Countries

Pharmacoepidemiology and Drug Safety, Volume 35, Issue 6, June 2026.
ABSTRACT Background Digital databases such as pharmacovigilance (PV) databases could provide unique opportunities to monitor trends in suspected antibiotic resistance, ineffectiveness, and misuse, extending beyond their traditional role of tracking adverse drug reactions (ADRs).
Hager Saleh, Joseph Mitchell, Cecilia Stålsby Lundborg, Megha Sharma   +3 more
wiley   +1 more source

Age‐Dependent Differences in Canakinumab Safety: A Comprehensive Pharmacovigilance Analysis Using the FAERS Database

Pharmacology Research &Perspectives, Volume 14, Issue 3, June 2026.
ABSTRACT While the efficacy of canakinumab, an anti‐interleukin‐1β monoclonal antibody, is well‐established, its safety profile, particularly across different age groups, remains inadequately explored. Using the FDA Adverse Event Reporting System (FAERS) database, this study evaluated postmarketing safety by analyzing adverse event (AE) reports from ...
Youyang Wang, Ngasin Lam, Xiaoming Huang, Yang Jiao   +3 more
wiley   +1 more source

Three Essays on Food and Drug Administration's Postmarketing Studies on Prescription Drugs in the United States

, 2019
With a paradigm shift from an approval-oriented approach to a lifecycle management approach and increasing demand for expedited approvals and drug safety, the importance of postmarketing studies has been emphasized in drug regulatory and policy ...
Yoon, Nami
core  

Recent Advances and Future Directions in Bellafill as a Regenerative Biomaterial: Biological Mechanisms, Clinical Applications, and Safety

Journal of Cosmetic Dermatology, Volume 25, Issue 6, June 2026.
ABSTRACT Background Bellafill is a polymethylmethacrylate (PMMA) microsphere‐collagen composite increasingly recognized as a scaffold‐based injectable biomaterial rather than a temporary filler. Its non‐resorbable PMMA microspheres enable stable integration into host tissue and promote collagen neogenesis, fibroblast activation, and extracellular ...
Li Nan, Fang Xia, Ahmad Alhaskawi, Chenggang Yi, Pengchao Guo   +4 more
wiley   +1 more source

RE: Systematic postmarketing surveillance needed for misused psychoactive pharmaceutical drugs-[3]

, 2023
RE: Systematic postmarketing surveillance needed for misused psychoactive pharmaceutical drugs ...
Angela Rintoul (13091136), M D H Dobbin (13497625)   +1 more
core  

Adverse Drug Reaction Study of Botulinum Toxin‐A in the Real World

Journal of Cosmetic Dermatology, Volume 25, Issue 6, June 2026.
ABSTRACT Background Despite the increasing use of botulinum toxin type A (BoNT‐A) in aesthetic and therapeutic applications, its real‐world adverse drug reaction (ADR) profile remains incompletely characterized. Current evidence relies largely on small‐scale clinical observations rather than large, systematic analyses.
Jiaxu Gu, Yue Sun, Kexin Chen, Jieyi Wang, Bingcheng Lu, Hongqiang Xie, Xiaoming Liu, Cong Huang, Xingling Jian, Bo Yu   +9 more
wiley   +1 more source

Record Linkage Studies for Postmarketing Drug Surveillance: Data Quality and Validity Considerations

, 1988
Large automated databases are the source of information for many record linkage studies, including postmarketing drug surveillance. Despite this reliance on prerecorded data, there have been few attempts to assess data quality and validity. This article
Andy S. Stergachis
core   +1 more source

MDDC: An R and Python package for adverse event identification in pharmacovigilance data

Scientific Reports
The safety of medical products continues to be a significant health concern worldwide. Spontaneous reporting systems (SRS) and pharmacovigilance databases are essential tools for postmarketing surveillance of medical products.
Anran Liu, Raktim Mukhopadhyay, Marianthi Markatou   +2 more
doaj   +1 more source

Systematic postmarketing surveillance needed for misused psychoactive pharmaceutical drugs.

, 2013
Systematic postmarketing surveillance needed for misused psychoactive pharmaceutical ...
Steve Moylan (13085862)
core  

Pharmacodynamic analysis of eribulin safety in breast cancer patients using real-world postmarketing surveillance data [PDF]

, 2018
Postmarketing surveillance is useful to collect safety data in real-world clinical settings. In this study, we applied postmarketing real-world data on a mechanistic model analysis for neutropenic profiles of eribulin in patients with recurrent or ...
Takahisa Kawamura, Kawamura, Takahisa,, Toshiaki Takahashi, Mika Ishii, Ishii, Mika,, Ishii, Mika, Hidefumi Kasai, Toshiyuki Matsuoka, Tanigawara, Yusuke, Kasai, Hidefumi,, Takahashi, Toshiaki, Fermanelli, Valentina,, Sakata, Yukinori,, Yukinori Sakata, Takahashi, Toshiaki,, Kawamura, Takahisa, Fermanelli, Valentina, Kasai, Hidefumi, Sakata, Yukinori, Matsuoka, Toshiyuki,, Yusuke Tanigawara, Matsuoka, Toshiyuki, Valentina Fermanelli, Tanigawara, Yusuke,   +23 more
core   +1 more source